Figure 1.
Unadjusted Kaplan-Meier estimates of relapse-free survival stratified by recipient cytomegalovirus (CMV) serostatus at the time of transplantation (A), receipt of antilymphocyte therapy (ALT) within 1 year prior to the completion of CMV treatment (B), and peak viral load (VL) (C). P values refer to log-rank test results (n = 170).